Company news
Feedback Plc (LSE:FDBK) news
Feedback Plc news releases on 6ix. Latest, Jan 24, 2019: Half-year Results
Press releases — page 3
Half-year Results
January 24, 2019
Feedback retains industry standard certification
November 22, 2018
Notice of General Meeting
October 29, 2018
Proposed placing and subscription to raise £1.375m
October 25, 2018
Expansion of European customer base
October 22, 2018
Appointment of Joint Broker
October 1, 2018
TexRAD® ordered by Samsung Medical Centre in Seoul
September 10, 2018
First GE Healthcare order for TexRAD®
August 15, 2018
Joint broker update
July 6, 2018
Grant of Options and Director/PDMR Dealing
June 27, 2018
Revised strategy to build a global company
June 7, 2018
Appointment of new Medical Director
June 1, 2018
Two-year contract with Royal Papworth Hospital
April 27, 2018
Distribution agreement with GE Healthcare
April 25, 2018
New Company Structure and Directorate Change
April 16, 2018
Equity Fundraising to raise £440,000
March 29, 2018
Presentation at RSNA 2017
November 22, 2017
First CE marked release of TexRAD® technology
November 20, 2017
CCI Exclusive Distributor agreement with Boya
July 28, 2017
Issue of Equity
June 30, 2017
CCI Exclusive Distributor Agreement with Korea ISG
June 8, 2017
Further re. Notice of Resignation of Director
May 30, 2017
Progress with CE Mark and trading update
May 18, 2017
Notice of Resignation of Director
May 2, 2017
Letter of Intent signed and trading update
March 30, 2017
Re: Media Articles
January 23, 2017
Issue of Equity & Director / PDMR Shareholding
November 23, 2016
Attendance at RSNA 2016
November 16, 2016
Re: Directorate
October 19, 2016
Collaboration with Future Processing
July 28, 2016
Appointment of Non-Executive Chairman
June 1, 2016
Disposal
May 3, 2016
Change of Nominated Adviser
March 2, 2016
Interim Results for the 6 months ended 30 Nov 2015
February 22, 2016
TexRAD Update
November 23, 2015
Strategy Update
October 8, 2015
NHS publication on potential application of TexRAD
October 6, 2015
TexRAD Prostate Cancer Product Development
October 5, 2015
Licence of TexRAD to Stone Checker
September 28, 2015
First sale of TexRAD in China
September 9, 2015
Study Results
July 20, 2015
Exercise of Options
July 9, 2015
First server sale of TexRAD in Canada
June 12, 2015
Stmnt re Share Price Movement
June 4, 2015
Collaboration with University of Texas
May 15, 2015
Preliminary results from the Oxford Stone Group
May 11, 2015
Drug Trial and Trading Update
April 29, 2015
Collaboration with Princess Alexandra Hospital, AU
April 28, 2015
First sale of TexRAD in South Korea
April 27, 2015
Adoption of TexRAD research software
April 20, 2015